| International Journal of Molecular Sciences | |
| Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts | |
| Karin Zins2  Anita Thomas2  Trevor Lucas2  Mouldy Sioud1  Seyedhossein Aharinejad2  | |
| [1] Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo N-0310, Norway; E-Mail:;Laboratory for Molecular Cellular Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna 1090, Austria; E-Mails: | |
| 关键词: prostate cancer; placental growth factor; xenograft model; tumor-host interaction; tumor angiogenesis; | |
| DOI : 10.3390/ijms140917958 | |
| 来源: mdpi | |
PDF
|
|
【 摘 要 】
The growth and vascularization of prostate cancer is dependent on interactions between cancer cells and supporting stromal cells. The primary stromal cell type found in prostate tumors is the carcinoma-associated fibroblast, which produces placental growth factor (PlGF). PlGF is a member of the vascular endothelial growth factor (VEGF) family of angiogenic molecules and PlGF mRNA levels increase after androgen deprivation therapy in prostate cancer. In this study, we show that PlGF has a direct dose-dependent proliferative effect on human PC-3 prostate cancer cells
【 授权许可】
CC BY
© 2013 by the authors; licensee MDPI, Basel, Switzerland
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202003190033582ZK.pdf | 848KB |
PDF